Your browser doesn't support javascript.
loading
Temozolomide cytoreductive treatment in a giant cabergoline-resistant prolactin-secreting pituitary neuroendocrine tumor.
Ceccato, Filippo; Lombardi, Giuseppe; Albiger, Nora; Mazzai, Linda; Pambuku, Ardi; Rolma, Giuseppe; Zagonel, Vittorina; Scaroni, Carla.
Afiliação
  • Ceccato F; Endocrinology Unit, Department of Medicine (DMID).
  • Lombardi G; Department of Neurosciences (DNS), University of Padova.
  • Albiger N; Department of Experimental and Clinical Oncology, Medical Oncology 1, Veneto Institute of Oncology (IOV) - IRCCS, Padova, Italy.
  • Mazzai L; Endocrinology Unit, Department of Medicine (DMID).
  • Pambuku A; Neuroradiology Unit, University-Hospital of Padova.
  • Rolma G; Department of Experimental and Clinical Oncology, Medical Oncology 1, Veneto Institute of Oncology (IOV) - IRCCS, Padova, Italy.
  • Zagonel V; Neuroradiology Unit, University-Hospital of Padova.
  • Scaroni C; Department of Experimental and Clinical Oncology, Medical Oncology 1, Veneto Institute of Oncology (IOV) - IRCCS, Padova, Italy.
Anticancer Drugs ; 30(5): 533-536, 2019 06.
Article em En | MEDLINE | ID: mdl-30986806
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article